Jazz Pharmaceuticals Prevails in Patent Infringement Suit Against Avadel
Jazz Pharmaceuticals Inc. has claimed a victory in a recent intellectual property suit. A Delaware federal jury ruled on Monday that Avadel, a specialty drugmaker, must pay nearly $234,000 to Jazz Pharmaceuticals. This decision comes as a result of Avadel’s use of a patented process owned by Jazz Pharmaceuticals for a new narcolepsy drug, which…